The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.

Naminatsu TakaharaYousuke NakaiKei SaitoTakashi SasakiYukari SuzukiAkiyuki InokumaHiroki OyamaSachiko KanaiTatsunori SuzukiTatsuya SatoRyunosuke HakutaKazunaga IshigakiTomotaka SaitoTsuyoshi HamadaSuguru MizunoHirofumi KogureMinoru TadaHiroyuki IsayamaKazuhiko Koike

Published in: Journal of gastroenterology and hepatology (2020)

Age and comorbidity burden did affect OS and safety profile in BTC patients undergoing first-line palliative chemotherapy. ACCI can be a simple and useful tool to evaluate the age and comorbidity burden in these patients.

Keyphrases

patients undergoing
end stage renal disease
palliative care
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
prognostic factors
papillary thyroid
advanced cancer
squamous cell carcinoma
patient reported outcomes
radiation therapy